Novavax reported $0.13 in EPS Earnings Per Share for its fiscal quarter ending in December of 2025.





Eps Change Date
Adma Biologics USD 0.2 0.05 Dec/2025
Agenus USD -0.3 0.84 Dec/2025
AstraZeneca USD 2.58 0.46 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Cassava Sciences USD -0.26 0.04 Dec/2025
Geron USD -0.05 0.02 Dec/2025
GlaxoSmithKline GBP 0.43 0.17 Mar/2026
MannKind USD 0.01 0.06 Dec/2025
Merck USD -1.28 3.32 Mar/2026
Minerva Neurosciences USD -0.56 3.53 Dec/2024
Moderna USD -3.4 1.29 Mar/2026
Novartis USD 1.99 0.45 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
Sanofi EUR 1.88 0.35 Mar/2026
Sarepta Therapeutics USD -3.58 3.45 Dec/2025
TG Therapeutics USD 0.14 2.29 Dec/2025